Program Information
A New Optimization Method for Pre-Treatment Patient-Specific Stopping-Power by Combining Proton Radiography and X-Ray CT
C Collins-Fekete1,3,4*, R Schulte2 , L Beaulieu1,3 , J Seco4,5 , (1) Universite Laval, Quebec, Quebec, (2) Loma Linda University, Loma Linda, CA, (3) Centre Hospitalier University de Quebec, Quebec, QC, (4) Mass General Hospital; Harvard Medical, Boston , MA, (5) Department of Medical Physics in Radiooncology, DKFZ German Cancer Research Cente
Presentations
TU-FG-BRB-4 (Tuesday, August 2, 2016) 1:45 PM - 3:45 PM Room: Ballroom B
Purpose: The relative stopping power (RSP) uncertainty is the largest contributor to the range uncertainty in proton therapy. The purpose of this work is to develop a robust and systematic method that yields accurate patient specific RSPs by combining pre-treatment X-ray CT and daily proton radiography.
Methods: The method is formulated as a penalized least squares optimization (PLSO) problem min(|Ax-B|). The matrix A represents the cumulative path-length crossed in each material computed by calculating proton trajectories through the X-ray CT. The material RSPs are denoted by x and B is the pRad, expressed as water equivalent thickness. The equation is solved using a convex-conic optimizer. Geant4 simulations were made to assess the feasibility of the method. RSP extracted from the Geant4 materials were used as a reference and the clinical HU-RSP curve as a comparison. The PLSO was first tested on a Gammex RMI-467 phantom. Then, anthropomorphic phantoms of the head, pelvis and lung were studied and resulting RSPs were evaluated. A pencil beam was generated in each phantom to evaluate the proton range accuracy achievable by using the optimized RSPs. Finally, experimental data of a pediatric head phantom (CIRS) were acquired using a recently completed experimental pCT scanner.
Results: Numerical simulations showed precise RSP (<0.75%) for Gammex materials except low-density lung (LN-300) (1.2%). Accurate RSP have been obtained for the head (μ=-0.10%, 1.5σ=1.12%), lung (μ=-0.33, 1.5σ=1.02%) and pelvis anthropomorphic phantoms (μ=0.12, 1.5σ=0,99%). The range precision has been improved with an average R80 difference to the reference (μ±1.5σ) of -0.20±0.35%, -0.47±0.92% and -0.06±0.17% in the head, lung and pelvis phantoms respectively, compared to the 3.5% clinical margin. Experimental HU-RSP curve have been produced on the CIRS pediatric head.
Conclusion: The proposed PLSO with prior knowledge X-ray CT shows promising potential (R80 σ<1.0% over all sites) to decrease the range uncertainty.
Contact Email: